Advancing the field of cell and gene therapy is at the heart of Miltenyi Biotec. For more than three decades, we have helped basic researchers, clinical investigators, and biopharmaceutical companies to discover and harness the power of immune cells for cellular therapies.
With our expertise in providing reagents, instruments, and services from research to clinical-grade, we are unique in enabling investigators to take early discoveries to clinical translation and commercial manufacturing. Whether your interest lies in immuno-oncology, regenerative medicine, or graft engineering, you’ll find comprehensive solutions to support a variety of cell manufacturing procedures.
Cell and gene therapies are revolutionizing medicine today and are a big promise for the future. Our cutting-edge technologies, workflows, and raw materials help you to design and enhance the body's immune system for efficient targeting. No matter where your journey begins – at the research bench, or on a translational or commercial level – take advantage of our broad CGT portfolio and take your next step.
- Blood DCs
Full workflow solutions for research and GMP manufacturing of immune cell-based treatments.
- CAR T
- CAR NK
Gene-engineering made easy from research bench to closed and fully automated GMP solutions.
Innovative tools and products for basic and translational stem cell production.
- CD34 enrichment
- TCRab(-19) depletion
- CD45RA depletion
Technologies for the depletion of unwanted cells from hematopoietic stem cell grafts to potentially overcome relapse and side effects such as graft-versus-host disease.
Customized Application (CAP) Service for the CliniMACS Prodigy Platform offers the translation of manual manufacturing processes into tailor-made, automated, GMP-compliant procedures. Our team of specialists configure and align predefined software modules in accordance with customer specifications.
Translating CGT manufacturing processes to commercial-scale production capacities is challenging. However, the CliniMACS Cell Factory capitalizes on the automated, closed-system cell processing of the CliniMACS Prodigy Platform. It reduces cleanroom requirements and enables scalable, parallel manufacturing of clinical cell products on multiple instruments – in one room. With our MACSQuant Flow Cytometer Platform we’ve added tailored and automated analytical tools for effective IPC/QC to your cell manufacturing workflow. Whatever your CGT vision is, we make sure you get there.
One of the biggest challenges in the cell and gene therapy field is finding the safest and most unobstructed path from pre-investigational new drug (IND) activities to commercialization. Overcoming the high-risk gaps caused by unknowns related to process and platform, missing expertise, and an evolving regulatory landscape is key for success.
Our Miltenyi Bioindustry team is your CDMO partner from therapeutic development to GMP lentiviral vector manufacturing and cell therapy production. We provide completely integrated solutions carefully engineered for unique cell therapies with gene therapy workflows. We deliver a seamless clinical experience with access to our cutting-edge technologies and resources for IND clearance and beyond.
Take advantage of tailor-made solutions on the CliniMACS Prodigy.